Crossref

1. Molecular probes targeting HER2 PET/CT and their application in advanced breast cancer

- Fang Gao

- Fengxu Liu

- Jun Wang

- Junfang Bi

- Luoping Zhai

- Dong Li

2. Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy

- Nina Eissler

- Renske Altena

- Ali Alhuseinalkhudhur

- Olga Bragina

- Joachim Feldwisch

- Guido Wuerth

- Annika Loftenius

- Nikolai Brun

- Rimma Axelsson

- Vladimir Tolmachev

- Jens Sörensen

- Fredrik Y. Frejd

3. HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging

- Betül Altunay

- Agnieszka Morgenroth

- Mohsen Beheshti

- Andreas Vogg

- Nicholas C. L. Wong

- Hong Hoi Ting

- Hans-Jürgen Biersack

- Elmar Stickeler

- Felix M. Mottaghy

4. Use of Radionuclide-Based Imaging Methods in Breast Cancer

- Betül Altunay

- Agnieszka Morgenroth

- Felix M. Mottaghy

5. Radiolabeled HER2-targeted molecular probes in breast cancer imaging: current knowledge and future prospective

- Fatemeh Movahed

- Ouldouz Navaei

- Shiva Taghlidi

- Maryam Nurzadeh

- Maryam Eslami gharaati

- Maryam Rabiei

6. Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer

- Xianwen Hu

- Dandan Li

- Yujie Fu

- Jiashen Zheng

- Zelong Feng

- Jiong Cai

- Pan Wang

7. Preparation, Characterization, and Radiolabeling of Anti‐HER2 scFv With Technetium Tricarbonyl and Stability Studies

- Negar Bozorgchami

- Maryam Ahmadzadeh

- Dara Hatamabadi

- Abdolreza Yazdani

- Soraya Shahhosseini

- Elham Mohit